Ultragenyx Pharmaceutical Inc. buy Cantor Fitzgerald
Start price
15.02.24
/
50%
€44.60
Target price
15.02.25
€105.84
Performance (%)
-12.11%
Price
16.05.24
€39.20
Summary
This prediction is currently active. The prediction for Ultragenyx Pharmaceutical Inc. disappoints with a performance of -12.11%. This prediction currently runs until 15.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 1.031% | 1.031% |
iShares Core DAX® | -0.051% | 4.829% |
iShares Nasdaq 100 | 1.659% | 2.417% |
iShares Nikkei 225® | 0.658% | -2.173% |
iShares S&P 500 | 0.964% | 2.547% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $114.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€39.80
03.05.24
03.05.24
€99.30
03.05.25
03.05.25
-1.51%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.40
05.04.24
05.04.24
€98.89
05.04.25
05.04.25
-15.52%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.60
27.02.24
27.02.24
€98.68
27.02.25
27.02.25
-20.97%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.20
19.01.24
19.01.24
€104.83
19.01.25
19.01.25
-5.97%
16.05.24
16.05.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
25.09.23
25.09.23
€107.74
25.09.24
25.09.24
9.88%
16.05.24
16.05.24